Skip to main content
. 2024 May 28;10(2):e003616. doi: 10.1136/rmdopen-2023-003616

Table 2.

Pregnancy outcome for pSS cases and control individuals

pSS (n=164) Controls (n=328) Adjusted OR 95% CI P value
Fetal loss* 36 (21.95%) 12 (3.66%)
Spontaneous miscarriage 21 (12.80%) 5 (1.52%) 11.335 (4.128 to 31.123) <0.001
Duration of spontaneous miscarriage (day)† 69.50±42.33 155.43±30.48
Therapeutic miscarriage 10 (6.10%) 3 (0.91%) 10.268 (2.646 to 39.846) 0.001
Other‡ 5 (3.05%) 4 (1.22%) 2.319 (0.572 to 9.412) 0.239
Oligohydramnios* 26 (15.85%) 35 (10.67%) 1.672 (0.936 to 2.989) 0.083
Eclampsia/pre-eclampsia* 2 (1.22%) 5 (1.52%) 0.319 (0.042 to 2.430) 0.270
Threatened preterm birth* 7 (4.27%) 3 (0.91%) 3.896 (0.925 to 16.412) 0.064
Premature rupture of membranes* 23 (14.02%) 56 (17.07%)
Premature rupture of membranes in preterm 16 (9.76%) 50 (15.24%) 0.728 (0.391 to 1.356) 0.317
Premature rupture of membranes in full term 7 (4.27%) 6 (1.83%) 1.671 (0.502 to 5.564) 0.403
Placental abnormalities on ultrasound* 24 (14.63%) 21 (6.40%) 2.295 (1.182 to 4.457) 0.014
 Placenta previa 6 (3.66%) 6 (1.83%)
 Placental abruption 1 (0.61%) 3 (0.91%)
 Hydatid mole 1 (0.61%) 0 (0%)
 Placenta implantation 3 (1.83%) 1 (0.30%)
 Placental adherence 9 (5.49%) 4 (1.22%)
 Placental thrombosis 1 (0.61%) 0 (0%)
 placental fibrin deposition 6 (3.66%) 0 (0%)
 Placental infarction 1 (0.61%) 0 (0%)
 Placental haematoma or bleeding 5 (3.05%) 5 (1.52%)
 Chorioamnionitis 4 (2.44%) 1 (0.30%)
 Veil-shaped placenta 2 (1.22%) 3 (0.91%)
 Racquet-shaped placenta 2 (1.22%) 1 (0.30%)
Pregnancy-induced hypertension* 6 (3.66%) 6 (1.83%) 2.367 (0.624 to 8.978) 0.205
Gestational diabetes mellitus* 18 (10.98%) 27 (8.23%) 1.339 (0.673 to 2.666) 0.406

Data were analysed by generalised linear regression method logistic.

*Number with the percentages between brackets.

†Mean±SD.

‡Including stillbirth, ectopic pregnancy, hydatidiform mole.

n, number of deliveries; pSS, primary Sjögren’s syndrome.